Vaxart

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Vaxart and other ETFs, options, and stocks.

About VXRT

Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology (VAAST) oral vaccine platform. Its investigational vaccines are administered using a room temperature-stable tablet, rather than by injection.

CEO

Andrei Floroiu

CEOAndrei Floroiu

Employees

125

Employees125

Headquarters

South San Francisco, California

HeadquartersSouth San Francisco, California

Founded

2004

Founded2004

Employees

125

Employees125

VXRT Key Statistics

Market cap

168.00M

Market cap168.00M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

2.68M

Average volume2.68M

High today

$1.35

High today$1.35

Low today

$1.27

Low today$1.27

Open price

$1.31

Open price$1.31

Volume

993.80K

Volume993.80K

52 Week high

$8.13

52 Week high$8.13

52 Week low

$1.26

52 Week low$1.26

VXRT News

Benzinga 6d

Vaxart to Present at World Vaccine & Immunotherapy Congress West Coast 2022 on November 29 - Vaxart (NASD - Benzinga

SOUTH SAN FRANCISCO, Calif., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Vaxart, Inc. VXRT today announced that Dr. Sean Tucker, Founder and Chief Scientific Officer, wil...

VXRT Earnings

-$0.24

-$0.16

-$0.08

$0.00

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Feb 23, After Hours

ActualExpected Feb 23, After Hours